November 6, 2017
Ariel Pablos-Méndez Joins TB Alliance Board of Directors
Dr. Pablos-Méndez brings decades of experience in strategies to improve the lives of the poor and most vulnerable people in the world October 30, 2017
TB Alliance Statement on WHO’s Global Tuberculosis Report 2017
TB continues to be the leading cause of death from a single infectious agent worldwide. October 10, 2017
TB Alliance Moves Two Novel Tuberculosis Drugs into Human Trials
TBA-7371 and Sutezolid Help Fill Sparse Pipeline of New Antibiotics Against a Disease That Grows Increasingly Resistant to Older Drugs September 27, 2017
TB Alliance Endorses WHO Designation of TB as a “Global Priority Pathogen”
New reports call for increased research and development funding August 31, 2017
WHO Prequalifies Childhood TB Medicine
TB Alliance led efforts to develop improved medicines for children with tuberculosis July 10, 2017
TB Alliance applauds G20 Communiqué
June 22, 2017
An Open Letter to Dr. Tedros
TB Alliance Congratulates New WHO Director-General May 11, 2017
EU Leaders Urge Funding of Critically-needed New Tools against Drug-resistant Tuberculosis
Participants at high-level meeting seek to end TB health threat in Europe March 24, 2017
TB Alliance Sublicenses Promising Anti-Tuberculosis Drug from the Medicines Patent Pool
Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer February 28, 2017